<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01248442</url>
  </required_header>
  <id_info>
    <org_study_id>ENM-EA-011</org_study_id>
    <nct_id>NCT01248442</nct_id>
  </id_info>
  <brief_title>Immune and Metabolic Effects of Vitamin D Supplementation in Healthy Humans</brief_title>
  <official_title>Placebo Controlled Study to Assess the Effects of Vitamin D Supplementation on Parameters of the Immune, Endocrine and Metabolic System in Healthy Women and Men.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this placebo controlled study the investigators aim to investigate the effect of a 3 month
      vitamin D supplementation on parameters of the immune, endocrine and metabolic system in
      healthy women and men. Vitamin D. In a pilot study the investigators showed an increase of
      certain immune cells, which regulate immunotolerance, the investigators therefore try to
      confirm these results with a placebo group. Furthermore the investigators assess the effect
      of vitamin D on the glucose metabolism and hormone levels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized double-blind placebo controlled trial, with the aim to investigate the
      effect of a Vitamin D supplementation on parameters of the immune, endocrine and metabolic
      system in healthy humans without diabetes and obesity.

      The primary aim is to assess the effect of vitamin D supplementation of the number and
      function of peripheral regulatory T-cells (Tregs). The investigators will measure the Tregs
      at baseline and monthly for 3 months. Furthermore the investigators assess additional immune
      cells from the adaptive immunosystem.

      Furthermore the investigators will perform a standard mixed meal tolerance test at baseline
      and 3 months following the supplementation in order to assess the insulin secretion in vivo.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Increase and function of peripheral regulatory T-cells</measure>
    <time_frame>3 months</time_frame>
    <description>The level and function of the regulatory T-cells will be compared between the two groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>immunophenotyping</measure>
    <time_frame>3 months</time_frame>
    <description>The effect of vitamin D on circulating immune cells and cytokine secretion will be measured at basal and after 3 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renin and aldosterone concentrations</measure>
    <time_frame>3 months</time_frame>
    <description>serum renin and aldosterone levels will be measured basal and after 3 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin secretion</measure>
    <time_frame>3 months</time_frame>
    <description>Insulin secretion assessed with a mixed meal tolerance test will be performed basal and after 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>calcium levels</measure>
    <time_frame>3 months</time_frame>
    <description>serum calcium levels will be measured basal and monthly for 3 months.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Healthy Humans</condition>
  <arm_group>
    <arm_group_label>Cholecalciferol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cholecalciferol</intervention_name>
    <description>monthly dose of 140.000 IU of cholecalciferol orally, 3 times.</description>
    <arm_group_label>Cholecalciferol</arm_group_label>
    <other_name>Oleovit D3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Matching Placebo</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Almondoil</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;= 10 years

          -  healthy subjects without chronic disease

        Exclusion Criteria:

          -  Hypercalcemia &gt;2,65 mmol/L

          -  pregnancy and lactation period

          -  acute infections

          -  chronic disease requiring treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas R Pieber, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Graz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University Graz</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2010</study_first_submitted>
  <study_first_submitted_qc>November 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2010</study_first_posted>
  <last_update_submitted>February 8, 2012</last_update_submitted>
  <last_update_submitted_qc>February 8, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vitamin D Deficiency</keyword>
  <keyword>Autoimmune disease</keyword>
  <keyword>Diabetes</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

